Averah Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 39.10%
- Profit Growth 2875.56%
- Ebitda -39.06%
- Net Worth 0.03%
- Total Assets 180.11%
About Averah Pharma
Averah Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 July 2006 and has a history of 18 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pramod Sharma, Girdhari Sharma, and Abhilasha Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233DL2006PTC150557
-
Company No.
150557
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jul 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Averah Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Sharma
|
Director | 01-Jan-2008 | Current |
|
Girdhari Sharma
|
Director | 01-Jun-2019 | Current |
|
Abhilasha Sharma
|
Additional Director | 01-Sep-2023 | Current |
Financial Performance of Averah Pharma.
Averah Pharma Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 39.1% increase. The company also saw a substantial improvement in profitability, with a 2875.56% increase in profit. The company's net worth moved up by a moderate rise of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Averah Pharma?
In 2018, Averah Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ksjn Chemicals Private LimitedPramod Sharma is a mutual person
-
Neelkanth Drugs Private LimitedPramod Sharma is a mutual person
-
Ssnd Medimart Private LimitedPramod Sharma and Abhilasha Sharma are mutual person
-
Arm Infraestate Private Limited
Pramod Sharma is a mutual person
-
Puerto Life Sciences Private Limited
Pramod Sharma is a mutual person
-
Ashajyoti Exports Private Limited
Pramod Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Averah Pharma?
Unlock and access historical data on people associated with Averah Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Averah Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Averah Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
